Blog About Us

107: Divi’s Laboratories expansion plans raise hopes for its stock

Mark to Market
Divi’s Laboratories stock has gained a whopping 83%. The firm’s capital expenditure plans has cheered investors. Its September quarter results too support the boost to valuations of the stock.
132 Episodes
21 Dec 2024
113: After slow IPO, Gland Pharma finds more takers in secondary markets
6 MINS
21 Dec 2024
112: Unexciting privatisation news flow keeps a check on BPCL shares
6 MINS
21 Dec 2024
111: India needs big promoter-led banks, and the RBI needs sharp sleuths to oversee them
6 MINS
21 Dec 2024
110: DBS Bank India’s rescue of Lakshmi Vilas Bank shows RBI has learnt finesse
6 MINS
21 Dec 2024
109: Aurobindo's US outlook improves but earnings may just be steady
6 MINS
21 Dec 2024
108: IndiGo top aviation stock globally, as vaccine adds fuel to valuations
6 MINS
21 Dec 2024
106: Gold loan lenders glitter, hope for growth to sustain
6 MINS
21 Dec 2024
105: HDFC shows swift recovery from pandemic with an upbeat outlook
6 MINS
21 Dec 2024
104: RIL factor makes Airtel shares lag behind, despite market share gains
4 MINS
21 Dec 2024
103: Axis Bank keeps provisioning spree but valuations reflect worry on asset quality
6 MINS
1 2 3 4 5 … 14

Creating Brand Stories via Immersive Audio that can mobilize the, Next Generation

Categories

Publishers

Other Links